It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
ZMapp is the drug that’s gotten the most attention so far. It’s a combination of three antibodies, proteins that bind and neutralize the Ebola virus. ZMapp has been administered to seven Ebola patients, and the manufacturer says its supplies have been exhausted. It is too early to know whether Will Pooley—the British nurse who contracted Ebola while caring for patients in Sierra Leone—will survive the disease. Two of the other six ZMapp recipients have died. Those who survived may have done so because they received good supportive treatment, because they were younger and didn’t have other medical problems, or by random chance (which is more likely to happen when you’re dealing with such small numbers). While ZMapp cured 18 primates infected with Ebola virus, there’s still much we don’t know. ZMapp still hasn’t yet been studied in humans.